Genetic ablation of the Rbpj gene reduced tumor burden in a spontaneous mouse model of breast cancer, indicating the absolute requirement of these monocyte-derived TAMs in supporting tumor growth (3). This evidence concerns the gene RBPJ and neoplasm.